14 results on '"Zabor, Emily C."'
Search Results
2. Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis
3. Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors
4. Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
5. Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations
6. The impact of BMI on outcomes of patients with metastatic renal cell carcinoma treated with targeted therapy: An external validation data set and analysis of underlying biology from The Cancer Genome Atlas.
7. Split-dose cisplatin as an alternative to every-3-week dosing when using cisplatin/gemcitabine to treat advanced urothelial cancer.
8. Efficacy of single-agent pemetrexed in platinum refractory metastatic urothelial cancer (mUC).
9. Targeted sequencing of upper tract urothelial carcinoma.
10. The high incidence of vascular thromboembolic events (VTE) in advanced urothelial cancer (UC) patients (pts) treated with carboplatin (Cb): Analysis of treatment with gemcitabine (G)/cb (GCb), gcb/bevacizumab (GCbBev), or gemcitabine/cisplatin (GCis).
11. Pilot investigation of variants in DNA repair pathways and association with response to platinum-based chemotherapy in bladder cancer.
12. Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND.
13. Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer
14. Prognostic implication of KIT mutations in melanoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.